<html>
<head>PUBMED IDs for AOF2</head>
<body bgcolor='#C5F0F2'><h1>AOF2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16079794/'>An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation.</a> August 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16079727/'>Thromboembolism after face lift because of mutation of the prothrombin gene.</a> August 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18424794/'>UniPrime: a workflow-based platform for improved universal primer design.</a> April 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21602794/'>LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.</a> August 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22245111/'>Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.</a> October 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22464800/'>The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.</a> June 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22847005/'>Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22992372/'>Integration of ERÎ±-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer.</a> June 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24687155/'>Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide Substrate.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24687146/'>Sleep and circadian rhythm regulation in early Parkinson disease.</a> July 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25755264/'>A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening.</a> March 25  2015<br></body></html>
